Crewe Advisors LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Crewe Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$1.63 - $3.52 $652 - $1,408	-400 Reduced 7.41%	5,000 $8,000
Q2 2022 Aug 02, 2022	BUY	$2.2 - $4.2 $11,000 - $21,000	5,000 Added 1250.0%	5,400 $13,000
Q1 2022 Apr 27, 2022	BUY	$2.83 - $8.69 $1,132 - $3,476	400 New	400 $2,000
Q4 2021 Feb 10, 2022	SELL	$8.31 - $14.92 $3,324 - $5,968	-400 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$9.15 - $13.28 $3,660 - $5,312	400 New	400 $5,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Crewe Advisors LLC with notifications on news.